Accuray slips as fiscal Q4 results miss forecasts
Shares of Accuray Inc. (Nasdaq:ARAY) are slipping in pre-market trading after the radio surgery system provider for the treatment of solid tumors reported fiscal fourth-quarter results that missed consensus estimates by a long shot. However, muting the stock’s slide in pricing action was that the company issued fiscal 2009 revenue guidance below to above the mean forecast on Wall Street.
Shares dipped 8%, or $0.57, to $7.00 in pre-market trading. For detailed price information and news stories on Accuray, click ARAY.
